Alkermes plc (ALKS)
NASDAQ · Healthcare
Alkermes plc EBITDA 2010–2025
Alkermes plc annual/quarterly ebitda history and growth rate from 2010 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Alkermes plc ebitda for the quarter ending March 31, 2026 was -28.9 M, a 236.01% decrease year-over-year.
- Alkermes plc ebitda for the twelve months ending March 31, 2026 was 51.5 M, a 166.59% decrease year-over-year.
- Alkermes plc annual ebitda for 2025 was 281.1 M, a 37.41% decrease from 2024.
- Alkermes plc annual ebitda for 2024 was 449.2 M, a 8.15% decrease from 2023.
- Alkermes plc annual ebitda for 2023 was 489.0 M, a 581.38% increase from 2022.
- Alkermes plc annual ebitda for 2022 was 71.8 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alkermes plc EBITDA — FAQ
Alkermes plc (ALKS) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALKS's ebitda history?
The chart and table above show Alkermes plc's ebitda by year and by quarter, including the growth rate.